Tech Company Financing Transactions
Luma Vision Funding Round
On 12/18/2023, Luma Vision raised $22 million in Series A funding from Atlantic Bridge Ventures, Bayern Kapital and EQT Life Sciences.
Transaction Overview
Company Name
Announced On
12/18/2023
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Series A
Investors
Atlantic Bridge Ventures (Lead Investor)
Bayern Kapital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to gain FDA clearance, prepare for U.S. commercialization and develop the next generations of its VERAFEYE platform for additional clinical applications in cardiology and beyond.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Balanstr. 69b, 3rd Floor
Munich, 81541
DE
Munich, 81541
DE
Phone
Undisclosed
Website
Email Address
Overview
LUMA Vision is a company that creates connected intra-vascular medical devices to aid in the treatment of cardiac arrhythmias. Through advanced four-dimensional imaging and artificial intelligence (AI), the company improves the way EP and structural heart interventions are treated, allowing doctors to perform cardiac treatments that improve patientoutcomes, increase procedural safety, and reduce healthcare system costs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fionn Lahart
Chief Technical Officer
Christoph Hennersperger
Browse more venture capital transactions:
Prev: 12/18/2023: Strike Graph venture capital transaction
Next: 12/18/2023: CareerFairy venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs